Stock Information

Stock Information

The following sections are made available to customers in order to provide in-depth information regarding stock performance and investment forecasts.

Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Historic Stock Lookup

Week of June 8, 2020

Date Requested Closing Price Volume Split Adjustment Factor Open Price Day High Day Low
June 8, 2020 $12.00 1,477,232 1:1 $11.90 $12.01 $11.89
June 9, 2020 $11.83 17,354,383 1:1 $12.00 $12.10 $11.82
June 10, 2020 0 1:1 $12.10 $11.82

Year End Stock Prices

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. The closing price above is not necessarily indicative of future price performance.

Investment Calculator

Investment Date Original Shares Original Value Current Shares Current Value % Return Split Adjustment Current price
Jan 02, 2014 1,000.00 $20,350.00 1,000.00 $11,830.00 -41.87% 1 $11.83

Return calculations do not include reinvested cash dividends.

Analyst Coverage

  • Boris Peaker

    Cowen and Company
    • Raghuram Selvaraju

      H.C. Wainwright & Co. Inc.
      • Jess Fye

        • Matthew Kaplan

          Ladenburg Thalmann & Co. Inc.
          • Jonathan Aschoff

            National Securities
            • Joseph Catanzaro

              Piper Jaffray
              • Jotin Marango

                Roth Capital Partners, Inc.
                • David Nierengarten

                  Wedbush Securities Inc.

                  Stemline Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Stemline Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stemline Therapeutics or its management. Stemline Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.